AstraZeneca
AstraZeneca Cancer Support Network (AZ CSN)
(866) 922-9276;
FAX (866) 279-0709;
8:00AM-8:00PM Eastern Time
Arimidex, Casodex, Faslodex, Zoladex
AZ CSN is a comprehensive service platform for physicians and patients designed to meet informational needs, provide access to product, and address coverage issues. Specially trained Registered Nurses, Pharmacists, and Reimbursement Specialists are available to personally address customer needs including a gateway to the AZ & Me Prescription Savings Program. More information can be obtained by visiting www.azcsn.net.

Bayer Healthcare Pharmaceuticals/Onyx Pharmaceuticals
CamCare;
Leukine Reimbursement Support Program
(800) 473-5832;
FAX (800) 513-1824;
9:00AM-5:00PM Eastern Time
Campath, Fludara, Leukine
This Program provides patient assistance and reimbursement support. CamCare’s nursing support line is available 24/7.

Nexavar REACH Program
(866) NEXAVAR (639-2827);
FAX (866) 639-5181;
9:00AM-8:00PM Eastern Time
Nexavar
The Program provides clinical information, insurance information, reimbursement support, prescription processing, and patient assistance to uninsured patients who meet the program eligibility criteria.

bioTheranostics
bioTheranostics discovers, develops and commercializes molecular diagnostic tests for cancer patients. Leveraging its unique expertise in genomic profiling and proprietary algorithms, bioTheranostics provides innovative tests to the oncology community that help drive personalized treatment. The company operates a CLIA-certified, CAP-accredited, diagnostic service laboratory in San Diego, California, to perform its proprietary molecular diagnostic tests: CancerTYPE ID®, a molecular cancer classifier particularly helpful for patients diagnosed with metastatic cancer whose tumor origin is either uncertain or unknown through conventional diagnostic testing; and the Breast Cancer Index®, which refines and improves risk stratification in patients with estrogen receptor (ER)-positive, lymph-node negative breast cancer. More information is available at www.biotheranostics.com.

Larry Hansen
V.P. Commercial Operations  |  bioTheranostics, Inc.
9640 Towne Centre Drive, Suite 200  |  San Diego, CA 92121
T  |  (858) 587-5866
F  |  (858) 587-5871
larry.hansen@biotheranostics.com
www.biotheranostics.com

Celgene
Innohep Support Services
(866) 742-7646
Innohep
Innohep Support Services provides reimbursement and patient assistance support.

Patient Support Coordinator (PSC) Program
(800) 931-8691;
FAX (800) 822-2496;
www.celgenepsc.com;
patientsupport@celgene.com
5:00AM-4:00PM Pacific Time
The Celgene Patient Support Coordinator (PSC) Program was created to help patients and healthcare providers navigate the challenges of reimbursement, provide information about co-pay assistance, and answer general questions about Celgene products and their distribution. The PSC is a dedicated central point of contact who assists providers and patients who rely on Celgene products. The RevAssist/STEPS telephone number is (888) 423-5436.

Vidaza Support Services
(866) 742-7646;
FAX (866) 369-4333;
8:00AM-8:00PM Eastern Time
Vidaza
Vidaza Support Services provides reimbursement and patient assistance support.

Celgene Corporation is pleased to announce ISTODAX (romidepsin) for injection is now approved for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least 1 prior therapy. ISTODAX is also approved for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least 1 prior systemic therapy. These indications are based on response rate. Clinical benefit such as improvement in overall survival has not been demonstrated.
Dosing and Administration
The recommended dose of romidepsin is 14 mg/m2 administered intravenously over a 4-hour period on days 1, 8, and 15 of a 28-day cycle. Cycles should be repeated every 28 days provided that the patient continues to benefit from and tolerates the therapy. Treatment discontinuation or interruption with or without dose reduction to 10 mg/m2 may be needed to manage adverse drug reactions.
Drug NDC and Coding
ISTODAX is supplied as a kit containing 1 single-use vial of 10 mg of romidepsin and 1 single-use vial of Diluent for romidepsin containing a 2 mL deliverable volume. The national drug code (NDC) for ISTODAX is 59572-983-01. The HCPCS Code for ISTODAX is J9315.
Storage
ISTODAX kit must be stored at 20°C to 25°C, excursions permitted between 15°C and 30°C. (See USP Controlled Room Temperature.)
Patient Assistance for ISTODAX
For more information regarding patient assistance for ISTODAX, contact Celgene Patient Support® at 1-800-931-8691. ISTODAX® (romidepsin) for injection is indicated for treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy. ISTODAX® (romidepsin) for injection is indicated for treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy. These indications are based on response rate. Clinical benefit such as improvement in overall survival has not
been demonstrated.

Please see accompanying full Prescribing Information, including WARNINGS AND PRECAUTIONS and
ADVERSE REACTIONS.

Eisai
Eisai Reimbursement Assistance Program
(877) 644-6270;
FAX (888) 644-7236;
8:00AM-8:00PM Eastern Time
Aloxi, Dacogen, Gliadel, Hexalen, Salogen
(866) 613-4724;
FAX (866) 573-4724;
Ontak, Panretin, Targretin
(866) 272-8804;
FAX (866) 272-8805;
Fragmin
The Eisai Reimbursement Assistance Program provides patient assistance and reimbursement support for Aloxi, Dacogen, Fragmin, Gliadel, Hexalen, Ontak, Panretin, Salogen, and Targretin. A customer service representative will assist with Eisai product information, indigent programs, reimbursement questions, prior authorizations, referral to co-pay assistance programs, insurance verification, billing/coding questions, appeal assistance, referral to disease-state assistance programs and letters of medical necessity.

Genentech BioOncology
Genentech Access Solutions
(888) 249-4918;
www.genentechaccesssolutions.com;
Avastin, Herceptin, Rituxan, Tarceva
Genentech Access Solutions provides one-stop access to a broad array of reimbursement information, and support and services for patients so that they can focus on treatment. In addition to providing information about co-pay assistance through independent public charities, Genentech Access Solutions can also help with common reimbursement challenges, insurance appeals and coverage denials, and referrals to the Genentech Access to Care Foundation. For coverage and reimbursement services, visit www.genentechaccesssolutions.com/
docs/av/ASEEnrollment.pdf for patient assistance, visit www.genentechaccesssolutions.com/
docs/av/GATCFEnrollment.pdf.

Avastin Patient Assistance Program
(888) 249-4918;
FAX (888) 249-4919;
6:00AM-5:00PM Pacific Time
The Avastin Patient Assistance Program is designed to limit the overall annual cost of Avastin for eligible patients receiving treatment for FDA-approved indications. Participation in the Program provides a voluntary opportunity for physicians and eligible patients who reach an annual charge of 10,000mg to receive free Avastin from Genentech for the remainder of the 12-month period. The Program is open to all patients receiving Avastin (regardless of insurance coverage) with a household adjusted gross income of up to $100,000. Patients must be receiving Avastin for an FDA-approved indication.

Genzyme Oncology
Clolar Direct Response Program
(800) RX-CLOLAR (800-792-5652);
FAX (866) 617-3001;
www.clolar.com/hcp/resources/cl_hc_re_direct.asp
9:00AM-5:00PM EST
Clolar
This support program provides a one-stop information resource for reimbursement and patient access questions. Staffed with specialists with expertise in public and private health insurance, the program offers assistance in securing payer coverage requirements, providing coding and billing information, verifying patient benefits, and accessing patient assistance resources.

ImClone Systems
BMS/ImClone Destination Access
(800) 861-0048;
FAX (888) 776-2370;
www.destinationaccess.com;
7:00AM-7:00PM
Erbitux
The BMS/ImClone Destination Access program helps with benefit investigation (appeals for physicians and patients, pre- & post-treatment appeals, Medicare Part B appeals, appeal FAQs) and patient assistance.

Lilly Oncology
Lilly Patient One
(866) 4PatOne;
FAX (866) 472-8663
Alimta, Gemzar
Lilly Oncology’s Patient One program provides reliable and individualized treatment support that addresses financial, access, and claim issues for patients who are candidates for Lilly’s oncology products. More information is available at www.lillypatientone.com/index.jsp.

Millennium
Velcade Reimbursement Assistance Program
(866) VELCADE;
9:00AM-8:00PM Eastern Time
Velcade
The Program provides product, clinical trials, and reimbursement information.

Novartis Oncology

Patient Assistance and Reimbursement Programs
Reimbursement Hotline: 800-282-7630
Patient Assistance Programs: 866-884-5906

Novartis is committed to providing access to our medications for those most in need. Through a variety of resources, including the Novartis Oncology Patient Assistance Program, the Novartis Oncology Reimbursement Hotline, and our support of independent Charitable Copay foundations, we have made a firm commitment to enable patients in need to access medicines.

Visit www.novartisoncology.us for complete patient assistance, reimbursement and clinical trail information. (This will link directly to Access to Medicine page)

Oncology Supply/ION
(888) 536-7697
OS/ION offers a unique value to pharmaceutical companies, service providers, and physician practices. Access provided by OS/ION empowers health care providers and industry companies to improve the efficiency, effectiveness, and quality of health care delivery to patients while enabling them to satisfy their respective missions. The collective portfolio of services and solutions from OS/ION include OS/ION Coding Workshops, monthly Web/teleconference workshops specifically for OS/ION members, which address pertinent topics such as basic coding rules and standards, and evaluation and management documentation requirements; OS/ION Medical Advisory Panel (MAP), comprising industry thought leaders with collective expertise in disease states, community-based practice, and business administration with an ongoing mission to deliver quality pharmaceutical products to patients as well as creative practice solutions to physicians; OS/ION Protocol Analyzer, a preloaded software program, complete with standard drug pricing from Oncology Supply and CMS’s most recent reimbursement data, which is available online at www.iononline.com, and calculates the overall cost of delivering chemotherapy in the practice; the OS/ION Pharmacy & Dispensing Program, with two distinct drug dispensing models that can be used to distribute medication for payment under the pharmacy benefits portion of a patient’s insurance and enables close analysis of each practice’s prescription-writing habits to determine which model is most suitable for use; OS/ION Practice Reimbursement Series, a series of reimbursement webinars that are designed to help network members stay abreast of breaking issues related to reimbursement and how it impacts them; OS/ION Vital Reimbursement Resources, a feature on the OS/ION Web site through which members are directed to an array of reimbursement material including CMS and Medicare enrollment forms, and timely news updates pertaining to reimbursement and legislation are posted in this section; and the overall OS/ION GPO Function, whereby the country’s largest diversified services organization for the community-based practitioner is designed to contract directly with pharmaceutical and biotech companies to support their products within the organization’s membership.

Ortho Biotech
DOXILine
(800) 609-1083;
FAX (800) 987-5572;
www.DOXILine.com;
9:00AM-8:00PM Eastern Time
Doxil
DOXILine provides access to reimbursement information and support—patient assistance program to patients without insurance coverage (based on financial need); access to insurance guidelines for private, federal, and state plans; verification of insurance coverage; and, coding and billing assistance.

ProcritLine
(800) 553-3851;
FAX (800) 987-5572;
www.procritline.com;
9:00AM-8:00PM Eastern Time
Leustatin, Procrit
ProcritLine provides easy access to reimbursement information and support—patient assistance program to patients without insurance coverage (based on financial need), coding and billing assistance, verification of insurance coverage, and assistance with appeals.

Pfizer Oncology
FirstRESOURCE
(877) 744-5675;
FAX (877) 744-5473;
9:00AM-7:00PM Eastern Time
Aromasin, Camptosar, Ellence, Sutent
FirstRESOURCE provides insurance benefit verification, prior authorization, payer cover policy, appeals assistance, alternative sources of coverage, and patient support program information.

Roche Oncology
Oncoline
(800) 443-6676;
8:30AM-5:00PM Eastern Time
Kytril, Roferon-A, Vesanoid, Xeloda
Oncoline offers a range of reimbursement and literature search services, including third-party payer reimbursement information, coverage and benefits verification, billing codes and claims procedures, assistance with appeals, clinical literature searches, and enrollment information for Roche’s Medical Needs Program.

Sanofi Aventis Oncology
Eligard Reimbursement Hotline
(877) 354-4273;
FAX (866) 354-4273;
9:00AM-8:00PM Eastern Time
Eligard
The Hotline provides patient assistance and reimbursement support.

Hyalgan Reimbursement Hotline
(800) 992-9022;
FAX (866) 354-4273;
9:00AM-8:00PM Eastern Time
Hyalgan
The Hotline provides patient assistance and reimbursement support.

PACT+ Program
(800) 996-6626;
FAX (800) 996-6627;
www.pactplusonline.com;
9:00AM-8:00PM Eastern Time
Anzemet, Elitek, Eloxatin, Nilandron, Taxotere
The PACT+ Program provides patient assistance, alternative resources, and reimbursement support to oncology patients and providers. The PACT+ Provider Portal is a secure web site accessible only to healthcare provides and reimbursement personnel who participate in the PACT+ Program on behalf of their practice’s needy patients. This tool is the first of its kind in oncology and offers improved workflow processes related to reimbursement and patient assistance program (PAP) information, such as the ability to streamline and prioritize PAP caseload, complete enrollment applications online, receive alerts and reminders about specific patient cases, track PAP product shipments, and easily access all patient related information including patient history, alerts/reminders, insurance benefit summaries, shipments, attachments, and case histories. To register for the PACT+ Provider Portal, visit www.pactplusonline.com or call (800) 996-6626.